Cargando…

Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure

Preferential usage of immunoglobulin (Ig) genes that encode antibodies (Abs) against various pathogens is rarely observed and the nature of their dominance is unclear in the context of stochastic recombination of Ig genes. The hypothesis that restricted usage of Ig genes predetermines the antibody s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorny, Miroslaw K., Sampson, Jared, Li, Huiguang, Jiang, Xunqing, Totrov, Maxim, Wang, Xiao-Hong, Williams, Constance, O'Neal, Timothy, Volsky, Barbara, Li, Liuzhe, Cardozo, Timothy, Nyambi, Phillipe, Zolla-Pazner, Susan, Kong, Xiang-Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229485/ https://www.ncbi.nlm.nih.gov/pubmed/22164215 http://dx.doi.org/10.1371/journal.pone.0027780

Ejemplares similares

Different Pattern of Immunoglobulin Gene Usage by HIV-1 Compared to Non-HIV-1 Antibodies Derived from the Same Infected Subject
por: Li, Liuzhe, et al.
Publicado: (2012)

Guinea pig immunoglobulin VH and VL naïve repertoire analysis
por: Matsuzawa, Shun, et al.
Publicado: (2018)

P04-10. Neutralization of Tier 1 and Tier 2 pseudoviruses by human anti-V3 monoclonal antibodies
por: Gorny, MK, et al.
Publicado: (2009)

Immunoprophylaxis against Mother-to-Child Transmission of HIV-1
por: Gorny, Miroslaw K, et al.
Publicado: (2006)

P12-13. Structure-guided design and immunological characterization of immunogen constructs presenting the HIV-1 gp120 V3 loop on a CTB scaffold
por: Totrov, M, et al.
Publicado: (2009)

GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains
por: Saxena, Gauri K., et al.
Publicado: (2020)

The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies
Publicado: (1991)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
por: Zolla-Pazner, S, et al.
Publicado: (2009)

Longitudinal Study of Primary HIV-1 Isolates in Drug-Naïve Individuals Reveals the Emergence of Variants Sensitive to Anti-HIV-1 Monoclonal Antibodies
por: Haldar, Bijayesh, et al.
Publicado: (2011)

P04-42. Molecular design of a mimotope that preserves conserved structural elements of the HIV-1 V3 crown
por: Jiang, X, et al.
Publicado: (2009)

Analysis of VH and VL mRNA in single synovial and peripheral B/plasma cells of patients with rheumatoid arthritis
por: Ruzickova, S, et al.
Publicado: (2001)

Effect of VH–VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding
por: Ling, Wei-Li, et al.
Publicado: (2018)

A facile technology for the high-throughput sequencing of the paired VH:VL and TCRβ:TCRα repertoires
por: Tanno, Hidetaka, et al.
Publicado: (2020)

High-resolution crystal structure of the Fv of quaternary neutralizing epitope mAb 2909 reveals atomic details of its antigen-binding site
por: Sampson, JM, et al.
Publicado: (2012)

Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells
por: Steinsbø, Øyvind, et al.
Publicado: (2014)

Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions
por: Yamauchi, Soichiro, et al.
Publicado: (2019)

Comparative Magnitude of Cross-Strain Conservation of HIV Variable Loop Neutralization Epitopes
por: Swetnam, James, et al.
Publicado: (2010)

Crystal structure analysis of anti-V2 mAb 2158 suggests a conformational epitope involving an N-linked glycan
por: Spurrier, B, et al.
Publicado: (2012)

Association of Diverse Genotypes and Phenotypes of Immune Cells and Immunoglobulins With the Course of HIV-1 Infection
por: Li, Liuzhe, et al.
Publicado: (2018)

Resistance of Subtype C HIV-1 Strains to Anti-V3 Loop Antibodies
por: Almond, David, et al.
Publicado: (2012)

Indirect Detection of an Epitope-Specific Response to HIV-1 gp120 Immunization in Human Subjects
por: Shmelkov, Evgeny, et al.
Publicado: (2011)

Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
por: Hioe, Catarina E., et al.
Publicado: (2010)

P20-09. Worldwide epitope prevalence of crystallographically resolved anti-V3 antibodies
por: Swetnam, J, et al.
Publicado: (2009)

Residue 315 regulates V3 exposure and V3 antibody recognition on HIV subtype B and C viruses
por: Manhas, S, et al.
Publicado: (2012)

Congenital Cataract in Gpr161(vl/vl) Mice Is Modified by Proximal Chromosome 15
por: Li, Bo I., et al.
Publicado: (2017)

P19-21. Sequence variability in the crown of the V3 loop of the HIV-1 envelope is clustered within a small 3D structural zone
por: Almond, D, et al.
Publicado: (2009)

Biophysical dissection of the antigen-antibody interaction of the broadly reactive anti-V3 human mAb 447-52D
por: Killikelly, A, et al.
Publicado: (2012)

Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials
por: Balasubramanian, Preetha, et al.
Publicado: (2018)

Targeted Immunology for Prevention and Cure of VL
por: Ali, Nahid, et al.
Publicado: (2014)

VH update
por: Arnold, Hannah
Publicado: (2022)

Identifying epitopes of HIV-1 that induce protective antibodies
por: Zolla-Pazner, Susan
Publicado: (2004)

Genomic analysis of mouse VL30 retrotransposons
por: Markopoulos, Georgios, et al.
Publicado: (2016)

Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral Proteins
por: Dadachova, Ekaterina, et al.
Publicado: (2006)

Evaluation of bioactive compounds produced by Nocardia levis MK-VL_113 & Streptomyces tendae TK-VL_333 for cytotoxic activity
por: Alapati, Kavitha, et al.
Publicado: (2013)

Assessment of treatment outcomes of visceral leishmaniasis (VL) treated cases and impact of COVID-19 on VL management and control services in Bangladesh
por: Maruf, Shomik, et al.
Publicado: (2023)

Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1
por: Hioe, Catarina E., et al.
Publicado: (2023)

Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity
por: Zolla-Pazner, Susan, et al.
Publicado: (2015)

VH: Theory and Experiment
por: Windischhofer, Philipp Jonas
Publicado: (2020)

VH WW in ATLAS
por: Kinghorn-taenzer, Joseph Peter
Publicado: (2015)

Pre-Clinical Evaluation of a (213)Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication
por: Dadachova, Ekaterina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k2lvcdjd4vtuj8f4t2gi9h3jlf